Showing results (1231-1240 of 5,724) with videos related to

Sort By:
Pageof 573
Medical Oncology (Northwood, London, England)|March 3, 2025
Deciphering FOXM1 regulation: implications for stemness and metabolic adaptations in glioblastomaKumari Swati, Saniya Arfin, Kirti Agrawal, et al.
Medical Oncology (Northwood, London, England)|September 1, 2024
How mitochondrial dynamics imbalance affects the progression of breast cancer:a mini reviewJingwen Kuang, Hao Liu, Linlin Feng, et al.
Medical Oncology (Northwood, London, England)|August 21, 2024
2-methoxyestradiol sensitizes tamoxifen-resistant MCF-7 breast cancer cells via downregulating HIF-1αYasmin M Attia, Hamada Ahmed Mokhlis, Ahmed Ismail, et al.
Medical Oncology (Northwood, London, England)|November 26, 2024
Associations between the life's essential 8, genetic risk and breast cancer incidence in premenopausal and postmenopausal women: a prospective study in UK BiobankZengle Zhao, Tongmin Chang, Xinjie Liu, et al.
Medical Oncology (Northwood, London, England)|November 14, 2024
Enhancing the understanding of doxorubicin's therapeutic impact in breast cancerZiye Zhuang, Rui Wang, Hao Chi
Medical Oncology (Northwood, London, England)|October 29, 2024
Targeting the undruggable in glioblastoma using nano-based intracellular drug deliverySakine Shirvalilou, Samideh Khoei, Reza Afzalipour, et al.
Medical Oncology (Northwood, London, England)|August 9, 2024
Diverse roles of aldolase enzymes in cancer development, drug resistance and therapeutic approaches as moonlighting enzymesFan Tang, Qingyang Cui
Medical Oncology (Northwood, London, England)|July 10, 2024
Small molecule inhibitors of the VEGF and tyrosine kinase for the treatment of cervical cancerFatima Sarwar, Samreen Ashhad, Archana Vimal, et al.
Medical Oncology (Northwood, London, England)|July 11, 2024
Anti-cancer potential of casein and its derivatives: novel strategies for cancer treatmentDaniel Romero-Trejo, Itzen Aguiñiga-Sanchez, Edgar Ledesma-Martínez, et al.
Medical Oncology (Northwood, London, England)|August 5, 2024
Tetrahydroisoquinoline reduces angiogenesis by interacting myeloma cells with HUVECs mediated by extracellular vesiclesAhmad Kooshari, Fahimeh Shahriyary, Minoo Shahidi, et al.
Pageof 573